WallStreetZenWallStreetZen

NASDAQ: CYTK
Cytokinetics Inc Stock Ownership - Who owns Cytokinetics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Cytokinetics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Fady Ibraham MalikEVP2026-11-033,500$62.93
$220.26kSell
Fady Ibraham MalikEVP2026-11-033,500$7.80
$27.30kBuy
Robert I. BlumCEO;Pres2026-11-027,500$62.81
$471.08kSell
Robert I. BlumCEO;Pres2026-11-027,500$10.60
$79.50kBuy
Fady Ibraham MalikEVP2026-10-203,500$7.80
$27.30kBuy
Fady Ibraham MalikEVP2026-10-203,500$64.01
$224.04kSell
Wendell WierengaDirector2026-10-1697$63.92
$6.20kBuy
James M. DalyDirector2026-10-16195$63.92
$12.46kBuy
John T. HendersonDirector2026-10-16352$63.92
$22.50kBuy
Edward M. Md KayeDirector2026-10-16195$63.92
$12.46kBuy

1 of 19

CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CYTK insiders and whales buy or sell their stock.

CYTK Shareholders

What type of owners hold Cytokinetics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Michael Schmertzler6.98%9,730,131$546.64MInsider
Eastern Capital Ltd2.07%2,883,845$162.01MInsider
Bvf Partners L P0.33%463,244$26.03MInsider
Robert I. Blum0.21%291,042$16.35MInsider
James A. Spudich0.13%180,600$10.15MInsider
Fady Ibraham Malik0.11%153,902$8.65MInsider
David Cragg0.11%153,233$8.61MInsider
Stephen M. Dow0.10%145,000$8.15MInsider
Jeffrey Hessekiel0.08%107,943$6.06MInsider
Mark A. Schlossberg0.07%103,408$5.81MInsider

1 of 3

CYTK vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CYTK0.12%10.94%Net SellingNet Selling
CORT0.04%99.96%Net BuyingNet Selling
AXSM0.07%57.78%Net SellingNet Buying
RYTM0.11%13.44%Net SellingNet Selling
IMVT0.05%57.62%Net BuyingNet Selling
View Top Biotech Stocks

Cytokinetics Stock Ownership FAQ

Who owns Cytokinetics?

Cytokinetics (NASDAQ: CYTK) is owned by 0.12% institutional shareholders, 10.94% Cytokinetics insiders, and 88.95% retail investors. Michael Schmertzler is the largest individual Cytokinetics shareholder, owning 9.73M shares representing 6.98% of the company. Michael Schmertzler's Cytokinetics shares are currently valued at $569.50M.

If you're new to stock investing, here's how to buy Cytokinetics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.